Future prospects and commercial viability of two-dimensional nanostructures for biomedical technology

Abstract The recent rapid advances in two-dimensional (2D) nanostructures have scripted a new episode in the healthcare sector including therapeutics, diagnostic imaging, theranostics, bioelectronic devices, biosensors, and so on. 2D nanostructures seem to attract investments and business from all over the world. However, the primary challenge confronting the commercialization of 2D nanomaterials includes their in vivo biosafety concerns and biocompatibility. The pivotal role of science, technology, and innovation is highlighted together with scrutinizing a library of 2D nanostructures having profound biomedical applications. The long-term picture of the “sprout of 2D nanostructures” to address many unmet biomedical commercial needs is delved into to meet the future demands of trade and business. The vision of updating the road map of technology transfer from research and development and start-ups to make significant headway onto the marketplace, marked by skepticism and hope, seems to be on the horizon.